Drug major Sun Pharmaceutical Industries on Friday reported an over two-fold rise in its consolidated net profit to Rs 1,852.48 crore for the quarter ended December on account of robust sales in most markets.
The company had posted a net profit of Rs 913.52 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing.
Consolidated total revenue from operations of the company stood at Rs 8,836.78 crore for the quarter under consideration. It was Rs 8,154.85 crore for the same period a year ago, it added.
Shares of Sun Pharmaceutical Industries were trading afternoon at Rs 574.20 per scrip on BSE, up 1.74 per cent over previous close.
Deccan Herald is on WhatsApp Channels | Join now for Breaking News & Editor's Picks